Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Trop Med Infect Dis ; 8(8)2023 Aug 08.
Article in English | MEDLINE | ID: mdl-37624341

ABSTRACT

Currently, more than 500,000 cases of various helminthes in humans are reported annually in the Russian Federation. This figure may not reflect the true incidence of helminthes, as only nine separate nosological forms are compulsory notifiable. The rest of the species of detected helminthes are included in a separate category of "other helminthes" or "rare helminthes". The bulk of the latter is represented by the helminthes with a rate of incidence that does not exceed one case per 100,000 people. This review is based on data derived from publications in the Russian language, both from the Russian Federation and international, as well as data available from various health treatment facilities in Russia. These data largely cover the period of the 1990s-2010s. A total of 15 species of "rare helminthes" are described in this review: anisakiosis, capillariosis, clonorchosis, dioctophymosis, dipylidiosis, echinochasmosis, fasciolosis, gastrodiscoidosis (amphistomiosis), metagonimosis, metorchiosis, nanophyetosis, pseudamphistomosis, sparganosis (spirometrosis), strongyloidosis and trichostrongylosis. Details of their geographical distribution, clinical and epidemiological peculiarities, and the difficulties they pose in diagnosis are provided. The public health importance of "rare helminthes" in Russia at present and in the forthcoming years is stressed.

2.
Article in English | MEDLINE | ID: mdl-35270788

ABSTRACT

Human dirofilariasis is a vector-borne helminth disease caused by two species of Dirofilaria: D. repens and D. immitis. The vectors of the helminth are mosquitoes in the family Culicidae. The definitive hosts of Dirofilaria are dogs and, to a lesser extent, cats. Humans are accidental hosts. Dirofilariasis has been reported in the territory of Russia since 1915. Sporadic cases of the disease have been reported occasionally, but the number of cases showed a distinct increasing trend in the late 1980s-early 1990s, when the number of cases reached several hundred in the southern territories of Russia, with geographic coordinates of 43° N-45° N. A comparison of the timing of the global trend of climate warming during the 1990s with the temporal pattern of the incidence of dirofilariasis in the territory of Russia indicated a close association between the two phenomena. At present, the northern range of Dirofilaria includes latitudes higher than 58° in both the European and Asian parts of the country. The phenomenon of climate warming in the territory of Russia has shaped the contemporary epidemiology of the disease. The emerging public health problem of dirofilariasis in Russia warrants the establishment of a comprehensive epidemiological monitoring system.


Subject(s)
Culicidae , Dirofilaria immitis , Dirofilaria repens , Dirofilariasis , Animals , Climate Change , Dirofilariasis/epidemiology , Dogs , Humans , Mosquito Vectors
3.
Lancet ; 396(10255): 887-897, 2020 09 26.
Article in English | MEDLINE | ID: mdl-32896291

ABSTRACT

BACKGROUND: We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (rAd26-S and rAd5-S). We aimed to assess the safety and immunogenicity of two formulations (frozen and lyophilised) of this vaccine. METHODS: We did two open, non-randomised phase 1/2 studies at two hospitals in Russia. We enrolled healthy adult volunteers (men and women) aged 18-60 years to both studies. In phase 1 of each study, we administered intramuscularly on day 0 either one dose of rAd26-S or one dose of rAd5-S and assessed the safety of the two components for 28 days. In phase 2 of the study, which began no earlier than 5 days after phase 1 vaccination, we administered intramuscularly a prime-boost vaccination, with rAd26-S given on day 0 and rAd5-S on day 21. Primary outcome measures were antigen-specific humoral immunity (SARS-CoV-2-specific antibodies measured by ELISA on days 0, 14, 21, 28, and 42) and safety (number of participants with adverse events monitored throughout the study). Secondary outcome measures were antigen-specific cellular immunity (T-cell responses and interferon-γ concentration) and change in neutralising antibodies (detected with a SARS-CoV-2 neutralisation assay). These trials are registered with ClinicalTrials.gov, NCT04436471 and NCT04437875. FINDINGS: Between June 18 and Aug 3, 2020, we enrolled 76 participants to the two studies (38 in each study). In each study, nine volunteers received rAd26-S in phase 1, nine received rAd5-S in phase 1, and 20 received rAd26-S and rAd5-S in phase 2. Both vaccine formulations were safe and well tolerated. The most common adverse events were pain at injection site (44 [58%]), hyperthermia (38 [50%]), headache (32 [42%]), asthenia (21 [28%]), and muscle and joint pain (18 [24%]). Most adverse events were mild and no serious adverse events were detected. All participants produced antibodies to SARS-CoV-2 glycoprotein. At day 42, receptor binding domain-specific IgG titres were 14 703 with the frozen formulation and 11 143 with the lyophilised formulation, and neutralising antibodies were 49·25 with the frozen formulation and 45·95 with the lyophilised formulation, with a seroconversion rate of 100%. Cell-mediated responses were detected in all participants at day 28, with median cell proliferation of 2·5% CD4+ and 1·3% CD8+ with the frozen formulation, and a median cell proliferation of 1·3% CD4+ and 1·1% CD8+ with the lyophilised formulation. INTERPRETATION: The heterologous rAd26 and rAd5 vector-based COVID-19 vaccine has a good safety profile and induced strong humoral and cellular immune responses in participants. Further investigation is needed of the effectiveness of this vaccine for prevention of COVID-19. FUNDING: Ministry of Health of the Russian Federation.


Subject(s)
Coronavirus Infections/prevention & control , Immunization, Secondary , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Viral Vaccines/immunology , Adenoviridae , Adult , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Betacoronavirus , COVID-19 , COVID-19 Vaccines , Coronavirus Infections/immunology , Female , Humans , Immunity, Cellular , Immunity, Humoral , Immunoglobulin G/blood , Injections, Intramuscular , Male , Russia , SARS-CoV-2 , Viral Vaccines/adverse effects , Young Adult
4.
Pathogens ; 9(4)2020 Apr 09.
Article in English | MEDLINE | ID: mdl-32283873

ABSTRACT

Dirofilariasis is a helminths vector-borne disease caused by two species of Dirofolaria-D.repens and D.immitis. The former is overwhelmingly associated with human dirofilariasis. The vector of the worm are mosquitoes of the family Culicidae (largely Culex, Aedes and Anopheles). The definitive hosts of Dirofilaria are dogs and to a lesser extent cats. Humans are an accidental host. A total of 1200 human cases caused by Dirofilaria were registered in the territory of the ex-USSR during the period 1915-2016. Zonal differences have been seen in the prevalence of infected dogs and mosquitoes. Studies undertaken in the southern part of the Russian Federation (RF) revealed the prevalence of Dirofilaria in dogs to be 20.8% with wild variations of larva density. Studies carried out in the central part of the RF found that the prevalence of parasites in dogs was 4.1%. Aedes mosquitoes were infected less than Culex and Anopheles mosquitoes. The latter were infected by D. repens more often than Culex and Aedes. Zonal differences were also traced in regard to Dirofilaria prevalence in humans, thus allowing identification of three zones of risk of infection (low, moderate, and stable), reflected in a series of constructed maps. Although Dirofilariasis was known on the territory of Russia from 1915, only sporadic cases of the disease were reported occasionally. Its number was showed an increasing trend only during the 1980s-1990s, reaching the level of hundreds of cases. The majority of cases were confined to the southern parts of Russia with geographic coordinates of 43°-45° on the northern latitude. Comparison of the timing of the global trend of climate warming during the 1990s with the temporal pattern of Dirofilaria on the territory of Russia during the same period demonstrated a close association between two phenomena. With the continuous process of global climate warming, the incidence of dirofilariasis both in man and dogs goes unabated exemplified by the territorial expansion of the disease northwards and eastwards attaining the latitude of 56°-57° on the northern latitude in the European and Asian parts of Russia. It appears that within the period of the last 20-25 years, the population at risk has doubled. Under these circumstances, dirofilariases in Russia should be considered as an emerging public health problem necessitating the establishment of a comprehensive epidemiological monitoring system with strong entomological and veterinary components. Based on the results obtained, an appropriate control intervention could be developed.

5.
PLoS One ; 14(7): e0219454, 2019.
Article in English | MEDLINE | ID: mdl-31291336

ABSTRACT

The association of latent toxoplasmosis with mental disorders in general and with schizophrenia in particular was noticed in the mid-1950s. In subsequent years, the role of Toxoplasma gondii was established based on its ability to survive for long periods of time in the nerve cells of the brain. The acute manifestations of the infection include psychopathic symptoms resembling those of schizophrenia. In the former USSR, and in other parts of the world, a number of studies were performed with respect to the association of latent toxoplasmosis and schizophrenia. However, with the dissolution of the USSR at the beginning of the 1990s, studies on the subject were halted due to financial problems and have resumed only recently. The reasons for the resumption of such studies in contemporary Russia are related to the progressively increasing incidence of schizophrenia over the last 25-30 years in the country. According to official data, approximately 550 000 persons reported suffering from the disease in 2014. There are reasons to believe that this is only a fraction of the real burden of the disease. Economically, it cost the state no less than approximately US $10 billion. The purpose of the study was to identify the level of toxoplasmosis seroprevalence in patients with verified diagnoses of schizophrenia in comparison to healthy people in Moscow City and in the Moscow region. A total of 155 persons constituted the patients group and 152 healthy people were in the control group. An integrated approach to the diagnosis and comparison of data from the entire spectrum of serological markers of infection was used, including the detection of specific IgM and the determination of IgG concentrations. It was found that among persons with neuropsychiatric disorders, the incidence of cases with latent toxoplasmosis was higher than in the control group. The effect of toxoplasmosis was significant and similar for men and women. Further statistical analyses revealed that among patients with a diagnosis of schizophrenia, the incidence of latent toxoplasmosis was significantly higher than in the control group. These data are in agreement with the results of similar studies in other countries.


Subject(s)
Mental Disorders/epidemiology , Schizophrenia/epidemiology , Toxoplasmosis/epidemiology , Adolescent , Adult , Brain/immunology , Brain/pathology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Mental Disorders/blood , Mental Disorders/complications , Mental Disorders/immunology , Middle Aged , Moscow/epidemiology , Neurons/immunology , Neurons/pathology , Russia/epidemiology , Schizophrenia/blood , Schizophrenia/complications , Schizophrenia/immunology , Seroepidemiologic Studies , Toxoplasma/immunology , Toxoplasma/pathogenicity , Toxoplasmosis/blood , Toxoplasmosis/complications , Toxoplasmosis/immunology , Young Adult
6.
Cardiol Res Pract ; 2019: 4836948, 2019.
Article in English | MEDLINE | ID: mdl-31210984

ABSTRACT

Cardiovascular pathology in patients with superinvasive opisthorchiasis is characterized by severe changes in haemodynamics and myocardial metabolism, impaired automatism, excitability, and conduction of the heart muscle. An analysis of 578 cases (medical and outpatient records and reports of pathoanatomical and forensic autopsies) recorded in healthcare facilities treating opisthorchiasis patients with a hyperendemic focus was carried out. We identified a set of cardiac changes in patients with hypereosinophilic syndrome associated with superinvasive opisthorchiasis infection, classified the pathological processes in accordance with ICD-10, and described their pathogenesis.

7.
Malar J ; 18(1): 178, 2019 May 22.
Article in English | MEDLINE | ID: mdl-31118029

ABSTRACT

Malaria control and preventive activities in the countries of the World Health Organization Region for Europe (WHO/EUR) were strengthened within the framework of the Regional Roll Back Malaria strategy adopted by the member-states at the beginning of the 2000s. A political document "From control to malaria elimination" known as the "Tashkent Declaration" was unanimously endorsed by the member-states of the WHO/EUR with malaria problems in 2005. Since then, considerable progress has been achieved in the countries of the region, signified by the dramatic reduction of malaria incidence in conjunction with the prevention of re-establishment of infection on the territories where malaria was eliminated earlier. Several countries of the region had been certified by the WHO as free of local malaria transmission as a result of the activities of their National Malaria Elimination Programme, Armenia being one of the first in 2011. One of the main lessons learnt during the implementation of the activities by the National Malaria Elimination Programme in Armenia was that the development of an operational plan for malaria elimination required a comprehensive national effort. Full support, both political and financial, from the highest levels of government to smooth coordination between different government ministries, such as Agriculture, Defense, Finance, Health and Policy and Planning and others, was a prerequisite for operational success. The role and place of various partners in the achievement of malaria elimination in the country is discussed in this review.


Subject(s)
Disease Eradication/statistics & numerical data , Malaria/prevention & control , World Health Organization , Armenia/epidemiology , Disease Eradication/methods , Government , Health Policy , Humans , Incidence , Malaria/epidemiology
8.
Malar J ; 17(1): 346, 2018 Oct 04.
Article in English | MEDLINE | ID: mdl-30286752

ABSTRACT

Presently, many malaria-endemic countries in the world are transitioning towards malaria elimination. Out of the 105 countries with ongoing malaria transmission, 10 countries are classified as being in the pre-elimination phase of malaria control, and 9 countries are in the malaria elimination stage, whereas 7 countries are classified as being in the prevention of introduction phase. Between 2000 and 2015, 17 countries eliminated malaria (i.e., attained zero indigenous cases for 3 years or more). Seven countries were certified by the WHO as having successfully eliminated malaria. The purpose of this review was to analyse the epidemiological characteristics of vivax malaria during the various stages of malaria eradication (elimination) programmes in different countries in the past and present. Experiences of the republics of the former USSR with malaria are interesting, particularly since the data overwhelmingly were published in Russian and might not be known to western readers. Among the most important characteristics of Plasmodium vivax epidemiology at present are changes in the ratio of the short-incubation P. vivax to long-incubation P. vivax, the incidence of severe P. vivax cases, the increased numbers of asymptomatic P. vivax cases, the reduced response to anti-malarials and a few others. Various factors contributing towards the peculiarities of P. vivax epidemiology are discussed.


Subject(s)
Disease Eradication , Malaria, Vivax/epidemiology , Plasmodium vivax/physiology , USSR/epidemiology
9.
PLoS One ; 12(9): e0184930, 2017.
Article in English | MEDLINE | ID: mdl-28957427

ABSTRACT

Studies carried out in Moscow residents have revealed that the prevalence of chronic toxoplasmosis is very close to those in countries of Eastern and Central Europe. Our findings also demonstrated a statistically significant relationship between the rate of traffic accidents and the seroprevalence of chronic toxoplasmosis in drivers who were held responsible for accidents. The latter was 2.37 times higher in drivers who were involved in road accidents compared with control groups. These results suggest that the consequences of chronic toxoplasmosis (particularly a slower reaction time and decreased concentration) might contribute to the peculiarities of the epidemiology of road traffic accidents in the Russian Federation and might interfere with the successful implementation of the Federal Programme named "Increase road traffic safety". Suggestions for how to address overcome this problem are discussed in this paper.


Subject(s)
Accidents, Traffic , Toxoplasmosis/epidemiology , Antibodies, Protozoan , Case-Control Studies , Chronic Disease , Female , Humans , Immunoglobulin G/immunology , Immunoglobulin M/immunology , Male , Prevalence , Russia/epidemiology , Toxoplasmosis/immunology
10.
Malar J ; 16(1): 226, 2017 05 30.
Article in English | MEDLINE | ID: mdl-28558764

ABSTRACT

Malaria was eliminated in Tajikistan by the beginning of the 1960s. However, sporadic introduced cases of malaria occurred subsequently probably as a result of transmission from infected mosquito Anopheles flying over river the Punj from the border areas of Afghanistan. During the 1970s and 1980s local outbreaks of malaria were reported in the southern districts bordering Afghanistan. The malaria situation dramatically changed during the 1990s following armed conflict and civil unrest in the newly independent Tajikistan, which paralyzed health services including the malaria control activities and a large-scale malaria epidemic occurred with more than 400,000 malaria cases. The malaria epidemic was contained by 1999 as a result of considerable financial input from the Government and the international community. Although Plasmodium falciparum constituted only about 5% of total malaria cases, reduction of its incidence was slower than that of Plasmodium vivax. To prevent increase in P. falciparum malaria both in terms of incidence and territory, a P. falciparum elimination programme in the Republic was launched in 200, jointly supported by the Government and the Global Fund for control of AIDS, tuberculosis and malaria. The main activities included the use of pyrethroids for the IRS with determined periodicity, deployment of mosquito nets, impregnated with insecticides, use of larvivorous fishes as a biological larvicide, implementation of small-scale environmental management, and use of personal protection methods by population under malaria risk. The malaria surveillance system was strengthened by the use of ACD, PCD, RCD and selective use of mass blood surveys. All detected cases were timely epidemiologically investigated and treated based on the results of laboratory diagnosis. As a result, by 2009, P. falciparum malaria was eliminated from all of Tajikistan, one year ahead of the originally targeted date. Elimination of P. falciparum also contributed towards speedy reduction of P. vivax incidence in Tajikistan.


Subject(s)
Disease Eradication , Malaria, Falciparum/prevention & control , Malaria, Vivax/prevention & control , Disease Eradication/methods , Humans , Malaria, Falciparum/epidemiology , Malaria, Vivax/epidemiology , Plasmodium falciparum/physiology , Plasmodium vivax/physiology , Tajikistan/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...